NextGen Sciences Divests Automation and Software Business to Focus on Protein Biomarker Services
The deal involves an exclusive license of the products the expressionfactory™, expressionworkstation™ and the controlling software suite orchestratorIMS™, to eXeTek, which is led by two former NextGen employees, Stephen Woodall and Stuart Hill. NextGen has acquired a 24% stake in eXeTek and 5% royalty on sales for three years as part of the deal. eXeTek will support the existing installed base globally, and will continue to sell the products and guide their future development.
Dr Michael Pisano, CEO of Nextgen Sciences, commented: “The sale of this part of the business will enable us to focus on our biomarkerexpress™ services. Existing customers of the products now supported by eXeTek will continue to receive the same high quality service, from the same team and with no break in cover.”
Other news from the department business & finance
These products might interest you
Limsophy by AAC Infotray
Optimise your laboratory processes with Limsophy LIMS
Seamless integration and process optimisation in laboratory data management
ERP-Software GUS-OS Suite by GUS
Holistic ERP solution for companies in the process industry
Integrate all departments for seamless collaboration
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.